The global mHealth apps market size was valued at USD 43.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2023 to 2030. Growing adoption of fitness and medical apps to collect and track individuals' health-related data and to improve the overall health of the patients’ using smartphones are the major factors anticipated to drive the market. In addition, increasing internet and smartphone penetration and growing awareness in maintaining physical health and lifestyle improvement are also further increasing the adoption, thereby supporting market growth.
Furthermore, increasing promotion to adopt health applications by the government and private organizations due to the benefits provided by these applications in monitoring and improving health conditions and lifestyle is also expected to accelerate the app adoption over the years. In addition, the growing number of health applications and continuous improvement of the app quality by the developers is also anticipated to boost the growth of the market for mHealth. For instance, according to statistics quoted by IQVIA in an article published by Medical Device Network in 2021, are more than 350,000 digital health applications available on app stores.
The growing interest of the users to use health applications for chronic disease management is expected to increase the adoption of mobile health applications. In addition, increasing recommendations of healthcare professionals to use mobile applications for better patient care is also another factor anticipated to accelerate the mHealth app adoption. For instance, according to the data published in OrthoLive stated that 93% of the healthcare professionals believed that mobile health applications can improve patients' health. This type of perspective of the healthcare professionals towards the mobile health applications is further anticipated to drive the adoption of the mHealth applications over the years.
Furthermore, an increase in the number of mobile subscriptions and growing internet penetration around the globe are further helping to boost the adoption of health applications. For instance, as per the report published in 2020 by Ericsson, the mobile subscription number exceeded six billion and this is also anticipated to increase over the forecast years. Moreover, the growing use of social media and increasing app promotions are also expected to propel the growth of the market for mHealth in the upcoming years. For instance, according to the DataReportal 2021 statistics, there are around 4.55 billion social media users by October 2021, which equates to 57.6% of the total world population.
In addition, there is an increase in the utilization of mHealth applications observed during the COVID-19 pandemic. During the pandemic, the government and non-government organizations promoted the use of mobile health applications for training, self-management of symptoms, information sharing, contact tracing, risk assessment, home monitoring, and decision making to manage the COVID-19 pandemic. For instance, as per the data published in the journal Expert Review of Pharmacoeconomics and Outcomes Research, there is a 65% growth in mobile health application download in 2020.
Moreover, data security and privacy concerns of mobile healthcare applications are the major factors expected to hamper the growth of the market for mHealth. Sensitive information accesses, hacking issues, data breaches, automatic installation of malicious programs are some of the major concerns anticipated to impede the market growth. In addition, lower regulatory approval for mHealth applications is also one of the major factors anticipated to restrain the growth of the market. For instance, as per the medical economics report, only 219 mobile health applications got FDA approval by 2018.
The medical apps segment dominated the market for mHealth in 2022 and accounted for the largest revenue share of 97.0%. Increasing awareness to adopt medical applications among the patients and healthcare professionals for better communication and healthcare outcomes is helping in boosting the segment share. In addition, long-term use of subscribed medical applications by the patient and physicians is also one of the major factors expected to drive the segment. In addition, increasing preference for medical applications to manage chronic disease conditions is propelling segment growth.
Moreover, the development of mobile medical applications to monitor patient health and to provide support to physicians for decision-making are other factors that are anticipated to boost segment growth in terms of revenue over the years. The fitness apps segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of fitness-related applications coupled with increasing awareness regarding self-health management. Growing emphasis on the adoption of a healthy lifestyle and increasing the use of wearable devices, tablets, and smartphones to access fitness apps is driving the segment. Moreover, growing awareness regarding diet-related diseases is anticipated to propel segment growth over the forecast period.
North America dominated the market for mHealth and accounted for the largest revenue share of 36.9% in 2022. Several factors like increasing awareness among the individuals to adopt mobile health applications, developments in coverage networks, rapid growth in the usage of smartphones, rise in geriatric population, and increasing prevalence of chronic diseases are driving the growth of the mHealth apps market in this region. In addition, increasing promotion by the healthcare professionals to use medical health applications in the U.S. is also leading to the adoption of such applications in this region.
Furthermore, due to the large population and increasing demand for health applications the Asia Pacific region is anticipated to exhibit lucrative growth over the forecast years. Fast-growing smartphone penetration and increasing internet users are also expected to drive the market for mHealth over the forecast period in this region. In addition, government initiatives to launch and promote mobile health applications to manage COVID-19 are also expected to boost the market growth in this region over the forecast years. For instance, in April 2020, the prime minister of India launched the Arogya Setu app to track the COVID 19 cases across India.
Increasing acceptance and adoption of mHealth apps by healthcare professionals and patients creates a competitive environment among the market players. Furthermore, the key strategies followed by the leading players in the form of mergers, collaborations, and acquisitions are also expected to accelerate market growth and fuel the competition. For example, in October 2019, Abbott Laboratories announced its partnership with Omada Health for diabetic care management using the mhealth coaching platform. Consequently, the developments by the leading players are anticipated to boost the growth of the market for mHealth over the forecast years. The key players are looking forward to developing cost-effective healthcare mobile applications as per the consumer need to hold their strong position in the market. Some of the prominent players in the mhealth apps market include:
Teladoc Health, Inc.
AstraZeneca PLC
Abbott Laboratories
Sanofi
Johnson and Johnson
Bristol-Myers Squibb Company
Novartis AG
F. Hoffmann-La Roche Ltd.
Merck and Co., Inc.
Pfizer, Inc.
GlaxoSmithKline plc
Samsung Electronics Co. Ltd
Orange
Qualcomm Technologies, Inc.
Google (Alphabet), Inc.
Airstrip Technologies, Inc.
Apple, Inc.
AT&T
Allscripts
Report Attribute |
Details |
Market size value in 2023 |
USD 49.2 billion |
Revenue forecast in 2030 |
USD 105.9 billion |
Growth Rate |
CAGR of 11.6% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2016 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, platform, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; Australia; China; Japan; India; South Korea; Singapore; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Teladoc Health, Inc.; Abbott Laboratories; Johnson and Johnson; AstraZeneca PLC; F. Hoffmann-La Roche Ltd.; Novartis AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer, Inc.; Sanofi; Samsung Electronics Co. Ltd.; Qualcomm Technologies, Inc.; Orange; Google (Alphabet), Inc.; Allscripts; Airstrip Technologies, Inc.; AT&T; Apple, Inc. |
Customization scope |
Free report customization (equivalent up to eight analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global mHealth apps market report on the basis of product type, Platform and region:
Product Type Outlook (Revenue, USD Million, 2016 - 2030)
Medical Apps
Women’s Health Apps
Personal Health Record Apps
Medication Management Apps
Diagnostic Apps
Remote Monitoring Apps
Disease Management Apps
Others
Fitness Apps
Diet & Nutrition
Exercise & Fitness
Lifestyle & Stress
Platform Outlook (Revenue, USD Million, 2016 - 2030)
Android
iOS
Others
Regional Outlook (Revenue, USD Million, 2016 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
Italy
France
Spain
Russia
Asia Pacific
Australia
China
Japan
South Korea
India
Singapore
Latin America
Mexico
Brazil
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
b. The global mHealth apps market size was estimated at USD 43.5 billion in 2022 and is expected to reach USD 49.2 billion in 2023.
b. The global mHealth apps market is expected to grow at a compound annual growth rate of 11.6% from 2023 to 2030 to reach USD 105.9 billion by 2030.
b. Medical apps dominated the mHealth apps market with a share of 97.0% in 2022. This is attributable to the high availability of a broad category of services that help a user manage and track different conditions.
b. Some key players operating in the mHealth apps market include Abbott Laboratories; Johnson and Johnson; AstraZeneca PLC; F. Hoffmann-La Roche Ltd.; Novartis AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer, Inc.; and Sanofi.
b. Key factors that are driving the mHealth apps market growth include the rising promotion of mHealth apps to create positive health outcomes along with the increasing preference for mobile apps.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.